Ginkgo Bioworks Holdings, Inc. DNA
Set alert
9.85 USD -1.36 -12.13%
At close · Nov 2
9.88 +0.03 +0.30%
After hours · Nov 2, 7:56 PM ET
9.28 Day range 11.25
5.48 52-week range 14.98
- YTD
- +18.53%
- 1 year
- -24.17%
- Open
- 11.35
- Prev close
- 11.21
- Mkt cap
- 663.30M
- Vol
- 3.55M
- Avg vol
- 2.23M
- EPS
- -4.45
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.28
- High
- 11.25
- Forward P/E
- -5.17
- Beta
- 1.79
- Short ratio
- 6.35
- Inst. own
- 73.73%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 8.08
- 200-d avg
- 8.32
- 1y target
- 7.00
MAX chart
Events in this range
- Aug 20, 2024Split: 1 for 40
- Sep 20, 2024Rating: TD Cowen · Buy → Buy
- Aug 7, 2025Earnings: -1.1; estimate -1.44; surprise 23.61%
- Aug 25, 2025Rating: BTIG · Sell → Sell
- Nov 6, 2025Earnings: -1.45; estimate -1.24; surprise -16.94%
- Jan 8, 2026Rating: TD Cowen · Buy → Buy
- Feb 26, 2026Earnings: -1.42; estimate -1.8; surprise 21.11%
- Mar 12, 2026Rating: BTIG · Sell → Sell
- May 7, 2026Earnings: -1.39; estimate -1.21115; surprise -14.77%
- Aug 5, 2026Earnings: -0.75; estimate -0.895; surprise 16.2%
- Aug 7, 2026Downgrade: TD Cowen · Buy → Hold
- Sep 4, 2026Rating: BTIG · Sell → Sell
- Nov 5, 2026Earnings: —; estimate -0.58; surprise —%
Signals (96)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 2026 | 1 day ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 23, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Feb 2, 2026 | 9 months ago |
Newest 20 of 96.
Financial health
Altman Z-Score
-8.71 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 4
Valuation
P/E -1.5×
FY 2019 5y median -1.5× FY 2025
P/S 2.7×
FY 2019 5y median 5.9× FY 2025
P/B 0.9×
FY 2019 5y median 1.6× FY 2025
P/FCF -2.6×
FY 2019 5y median -9.3× FY 2025
EV/EBITDA -2.9×
FY 2019 5y median -2.9× FY 2025
EV/Sales 4.3×
FY 2019 5y median 4.3× FY 2025
FCF Yield -38.8%
FY 2019 5y median -10.7% FY 2025
Profitability
Gross Margin 81.5%
FY 2019 5y median 78.5% FY 2025
Operating Margin -185.3%
FY 2019 5y median -343.8% FY 2025
Net Margin -183.8%
FY 2019 5y median -355.1% FY 2025
ROE -61.5%
FY 2019 5y median -81.4% FY 2025
ROIC -30.0%
FY 2019 5y median -56.9% FY 2025
ROA -27.9%
FY 2019 5y median -53.6% FY 2025
Growth (YoY)
Revenue -25.1%
FY 2019 FY 2025
Operating Income 43.7%
FY 2019 FY 2025
EPS (diluted) 46.5%
FY 2019 FY 2025
Free Cash Flow 53.2%
FY 2019 FY 2025
Financial Health
Current Ratio 4.9×
FY 2019 5y median 6.1× FY 2025
Quick Ratio 4.9×
FY 2019 5y median 6.1× FY 2025
Debt / Equity 0.9×
FY 2019 5y median 0.3× FY 2025
Net Debt / EBITDA -1.1×
FY 2019 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2019 5y median -5955× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31